NEW BRUNSWICK, N.J., Feb. 7, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
SOURCE Johnson & Johnson
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY54784&Transmission_Id=202202071651PR_NEWS_USPR_____NY54784&DateId=20220207)
Share this article